Publications: Mr Jozef Durko
Fyfe C, Fiorentino G, Steinbaugh M, Campos J, Lawson H, Durko J, O'Carroll D, Kranc K et al.
(
2022
)
.
Genetic and Pharmacological Inhibition of TUT4/TUT7 Sensitizes AML Cells to BCL-2 Inhibition
.
Blood
vol.
140
,
(
Supplement 1
)
12994
-
12994
.
Ragusa D, Suen C-W, Torregrosa G, Dijkhuis L, Byrne C, Balayo T, Tavosanis A, Durko J et al.
(
2022
)
.
Haemogenic Gastruloids Recapitulate Developmental Haematopoiesis and Provide an Ontogeny-Relevant Context to Dissect the Origins of Infant Leukemia
.
Blood
vol.
140
,
(
Supplement 1
)
1684
-
1685
.
Dembitz V, Lawson H, Philippe C, Burt RJ, James S, Magee ASM, Woodley K, Durko J et al.
(
2022
)
.
Inhibition of Stearoyl-CoA Desaturase Has Anti-Leukemic Properties in Acute Myeloid Leukemia
.
Blood
vol.
140
,
(
Supplement 1
)
3058
-
3060
.
Lawson H, Holt-Martyn J, Dembitz V, Durko J, Kabayama Y, Wang L, Van De Lagemaat L, Dubusse L et al.
(
2022
)
.
Targeting HIF-Hydroxylases Compromises Disease Initiation and Propagation, and Synergises with Current Therapies to Eliminate Cancer Stem Cells in AML
.
Blood
vol.
140
,
(
Supplement 1
)
8731
-
8732
.
Lawson H, van de Lagemaat LN, Barile M, Tavosanis A, Durko J, Villacreces A, Bellani A, Mapperley C et al.
(
2021
)
.
CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation
.
Stem Cell Reports
vol.
16
,
(
11
)
2784
-
2797
.
Lawson H, Sepulveda C, van de Lagemaat LN, Durko J, Barile M, Tavosanis A, Georges E, Shmakova A et al.
(
2021
)
.
JMJD6 promotes self-renewal and regenerative capacity of hematopoietic stem cells
.
Blood Advances
vol.
5
,
(
3
)
889
-
899
.
Mapperley C, Van De Lagemaat L, Lawson H, Tavosanis A, Paris J, Campos J, Wotherspoon D, Durko J et al.
(
2020
)
.
The mRNA m6A reader YTHDF2 supresses pro-inflammatory pathways and sustains hematopoietic stem cell function
.
Journal of Experimental Medicine
vol.
218
,
(
3
)
20200829
-
20200829
.